Insider Transactions Reported by 14 Insiders of Aravive, Inc.

Location
Houston, TX

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

Aravive, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fredric N. Eshelman Executive Chairman, Director, 10%+ Owner $23,473,906 24 Oct 2022
Eric Zhang Director $2,581,796 24 Oct 2022
Amato Giaccia Director $1,116,435 24 Oct 2022
Peter Tai-Ching Ho Director $101,838 24 Oct 2022
Maria Carolina Petrini Chief Commercial Officer 10 Apr 2023
Sigurd C. Kirk Director 23 Sep 2022
Gail Frances McIntyre CEO and President, Director 01 Feb 2023
Vinay Shah Chief Financial Officer 24 Jan 2022
Leonard Scott Dove Chief Operating Officer 01 Feb 2023
John Hohneker Director 23 Sep 2022
Robert B. Geller Chief Medical Officer 01 Feb 2023
Rudy Howard Chief Financial Officer 01 Feb 2023
Michael W. Rogers Director 23 Sep 2022
Reshma Rangwala Chief Medical Officer 24 Jan 2022

Recent Insider Transactions by Companies or Individuals for Aravive, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Maria Carolina Petrini Nonqualified Stock Option (Right to Buy) Award 400,000 400,000 10 Apr 2023 Direct
Robert B. Geller Stock Option (Right to Buy) Award 400,000 400,000 01 Feb 2023 Direct
Leonard Scott Dove Stock Option (Right to Buy) Award 400,000 400,000 01 Feb 2023 Direct
Gail Frances McIntyre Stock Option (Right to Buy) Award 700,000 700,000 01 Feb 2023 Direct
Rudy Howard Stock Option (Right to Buy) Award 400,000 400,000 01 Feb 2023 Direct
Peter Tai-Ching Ho Common stock Award 5435.3% 54,353 55,353 24 Oct 2022 See footnote
Peter Tai-Ching Ho Series B Warrants (right to buy) Award 27,176 27,176 24 Oct 2022 See footnote
Peter Tai-Ching Ho Series A Warrants (right to buy) Award 27,177 27,177 24 Oct 2022 See footnote
Eric Zhang Common stock Award 63.2% 543,537 1,403,303 24 Oct 2022 See footnote
Eric Zhang Series A Warrants (right to buy) Award 271,769 271,769 24 Oct 2022 See footnote
Eric Zhang Series B Warrants (right to buy) Award 271,768 271,768 24 Oct 2022 See footnote
Amato Giaccia Common stock Award 28.8% 271,768 1,213,648 24 Oct 2022 Direct
Amato Giaccia Series A Warrants (right to buy) Award 135,884 135,884 24 Oct 2022 Direct
Amato Giaccia Series B Warrants (right to buy) Award 135,884 135,884 24 Oct 2022 Direct
Gail Frances McIntyre Common stock Award 488% 54,353 65,490 24 Oct 2022 Direct
Gail Frances McIntyre Series A Warrants (right to buy) Award 27,177 27,177 24 Oct 2022 Direct
Gail Frances McIntyre Series B Warrants (right to buy) Award 27,176 27,176 24 Oct 2022 Direct
Rudy Howard Common stock Award 10,870 10,870 24 Oct 2022 Direct
Rudy Howard Series B Warrants (right to buy) Award 5,435 5,435 24 Oct 2022 Direct
Rudy Howard Series A Warrants (right to buy) Award 5,435 5,435 24 Oct 2022 Direct
Fredric N. Eshelman Common Stock Award 177% 16,306,120 25,517,889 24 Oct 2022 See footnote
Fredric N. Eshelman Series B Warrants (right to buy) Award 8,153,060 8,153,060 24 Oct 2022 See Footnote
Fredric N. Eshelman Series A Warrants (right to buy) Award 8,153,060 8,153,060 24 Oct 2022 See footnote
Amato Giaccia Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Peter Tai-Ching Ho Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
John Hohneker Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Eric Zhang Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Sigurd Kirk Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Michael W. Rogers Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Fredric N. Eshelman Stock Option (Right to Buy) Award 97,063 97,063 23 Sep 2022 Direct
Robert B. Geller Stock Option Award 200,000 200,000 01 Jul 2022 Direct
Rudy C. Howard Stock Option Award 290,000 290,000 03 Jun 2022 Direct
Fredric N. Eshelman Common Stock Options Exercise 97.4% 4,545,455 9,211,769 01 Apr 2022 See footnote
Fredric N. Eshelman Pre-Funded Warrant (right to buy) Options Exercise 4,545,455 0 01 Apr 2022 See footnote
Fredric N. Eshelman Common Stock Award 22.6% 860,216 4,666,314 29 Mar 2022 See Footnote 1
Fredric N. Eshelman Warrant (right to buy) Award 860,216 860,216 29 Mar 2022 See footnote
Leonard Scott Dove Stock Option (Right to buy) Award 200,000 200,000 21 Mar 2022 Direct
Vinay Shah Stock Option (Right to buy) Award 175,000 175,000 24 Jan 2022 Direct
Reshma Rangwala Stock Option (Right to buy) Award 175,000 175,000 24 Jan 2022 Direct
Gail Frances McIntyre Stock Option (Right to buy) Award 425,000 425,000 24 Jan 2022 Direct
Fredric N. Eshelman Pre-Funded Warrant (right to buy) Award 4,545,455 4,545,455 03 Jan 2022 See footnote
Amato Giaccia Common Stock Gift -4.88% -48,366 941,880 03 Dec 2021 Direct
Amato Giaccia Common Stock Sale -0.33% -3,245 990,246 30 Nov 2021 Direct
Amato Giaccia Common Stock Options Exercise 5.48% 51,611 993,491 30 Nov 2021 Direct
Amato Giaccia Stock Option Options Exercise -5.48% -500 8,620 30 Nov 2021 Direct
Amato Giaccia Stock Option Options Exercise -100% -51,111 0 30 Nov 2021 Direct
Peter Tai-Ching Ho Stock Option Award 22,812 22,812 10 Sep 2021 Direct
Amato Giaccia Stock Option Award 22,812 22,812 10 Sep 2021 Direct
Eric Zhang Stock Option Award 22,812 22,812 10 Sep 2021 Direct
John Hohneker Stock Option Award 22,812 22,812 10 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.